Mode
Text Size
Log in / Sign up
Phase 4 N=39 Randomized Treatment

Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children

Appendicitis

Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Jan 2022
Primary outcome: Primary: Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale - Parent — 91.3; 90.2 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Piperacillin/Tazobactam (Drug); Surgical Treatment (Procedure)
Age
Pediatric · 6+ yrs
Sex
All
Sponsor
NYU Langone Health
Primary completion
Dec 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale - Parent
91.3; 90.2
SECONDARY
Readmission Rates
25; 0
SECONDARY
Incidence of Long-term Complications in Medical Therapy Group
30

Summary

Several prior studies have demonstrated that medical management of acute appendicitis in adults is a safe first-line therapy option. This study aims to determine whether non-operative management of uncomplicated acute appendicitis with antibiotics is non-inferior to operative management in a pediatric population. This study will be a randomized controlled trial comparing non-operative management with antibiotics to surgical management of uncomplicated acute appendicitis. The hypothesis is that antibiotics are not worse than surgery for the treatment of uncomplicated appendicitis in children.

Eligibility Criteria

Inclusion Criteria

  • first episode of appendicitis
  • Pain < 48 hours
  • White blood cell count < 18,000
  • temperature < 103º F
  • radiographic evidence of acute appendicitis on ultrasound or CT without evidence of perforation
  • appendiceal diameter < 11 mm
  • ability to take oral antibiotics

Exclusion Criteria

  • Prior antibiotic treatment for appendicitis
  • presence of medical condition prohibiting surgical therapy
  • radiographic or clinical evidence of abscess or perforation
  • appendiceal mass, positive pregnancy test
  • other diagnosis equally as likely as appendicitis
  • pain for ≥ 48 hours, white blood cell count ≥ 18,000, temperature ≥ 103º F, or appendiceal diameter ≥ 11 mm
  • inability to take oral antibiotics.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02991937). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search